Caroline Ingre

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Caroline Ingres forskargrupp [1]
ALS Clinical Research Group [2]
[1] https://ki.se/cns/caroline-ingres-forskargrupp
[2] https://ki.se/en/cns/als-clinical-research-group

Artiklar

Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2024;25(7-8):795-796
THE INTERNATIONAL NETWORK FOR ALS RESEARCH AND CARE (INARC)
Foucher J; Bunte T; Verschoor R; Straub C; Couillard M; Bertone V
Article: JOURNAL OF NEUROLOGY. 2024;271(8):5267-5274
Repeated cognitive assessments show stable function over time in patients with ALS
Oijerstedt L; Foucher J; Lovik A; Yazdani S; Juto A; Klappe U; Fang F; Ingre C
Article: CLINICAL IMMUNOLOGY. 2024;265:110270
T cell subset composition differs between blood and cerebrospinal fluid in amyotrophic lateral sclerosis
Yazdani S; Lovik A; Seitz C; Ingre C; Fang F; Andersson J
Article: JOURNAL OF NEUROLOGY. 2024;271(8):5447-5459
Lifestyle and medical conditions in relation to ALS risk and progression-an introduction to the Swedish ALSrisc Study
Chourpiliadis C; Seitz C; Lovik A; Joyce EE; Pan L; Hu Y; Klappe U; Samuelsson K; Press R; Ingre C; Fang F
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2024;25(7-8):708-716
ECAS correlation with metabolic alterations on FDG-PET imaging in ALS
Foucher J; Oijerstedt L; Lovik A; Sun J; Ismail M-A; Sennfalt S; Savitcheva I; Estenberg U; Pagani M; Fang F; Pereira JB; Ingre C
Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2024;11(5):1280-1289
Motor band sign is specific for amyotrophic lateral sclerosis and corresponds to motor symptoms
Zejlon C; Sennfalt S; Finnsson J; Connolly B; Petersson S; Granberg T; Ingre C
Article: JOURNAL OF NEUROLOGY. 2024;271(5):2730-2735
Increased incidence of motor neuron disease in Sweden: a population-based study during 2002-2021
Imrell S; Fang F; Ingre C; Sennfaelt S
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2024;25(1-2):150-161
Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosis
Klappe U; Sennfalt S; Lovik A; Finn A; Bofaisal U; Zetterberg H; Blennow K; Piehl F; Kmezic I; Press R; Samuelsson K; Manberg A; Fang F; Ingre C
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2023;30(12):3722-3731
A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis
Weemering DN; Midei M; Milner P; Gopalakrishnan V; Kumar A; Dannenberg AJ; Bunte TM; Foucher J; Ingre C; Kenina V; Rallmann K; van den Berg LH; van Eijk RPA
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2023;30(9):2595-2601
Diagnostic delay in amyotrophic lateral sclerosis
Gwathmey KG; Corcia P; McDermott CJ; Genge A; Sennfalt S; de Carvalho M; Ingre C
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2023;24(7-8):1-6
Validity and reliability measures of the Swedish Karolinska version of the Edinburgh Cognitive and Behavioral ALS Screen (SK-ECAS)
Foucher J; Winroth I; Lovik A; Sennfalt S; Pereira JBB; Fang F; Lule D; Andersen PMM; Ingre C
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2023;24(5-6):485-494
FDG-PET shows weak correlation between focal motor weakness and brain metabolic alterations in ALS
Sennfalt S; Pagani M; Fang F; Savitcheva I; Estenberg U; Ingre C
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2023;24(5-6):523-534
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success
Shefner JM; Al-Chalabi A; Andrews JA; Chio A; De Carvalho M; Cockroft BM; Corcia P; Couratier P; Cudkowicz ME; Genge A; Hardiman O; Heiman-Patterson T; Henderson RD; Ingre C; Jackson CE; Johnston W; Lechtzin N; Ludolph A; Maragakis NJ; Miller TM; Mora Pardina JS; Petri S; Simmons Z; Van Den Berg LH; Zinman L; Kupfer S; Malik FI; Meng L; Simkins TJ; Wei J; Wolff AA; Rudnicki SA
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2023;24(5-6):389-393
PRECISION ALS-an integrated pan European patient data platform for ALS
McFarlane R; Galvin M; Heverin M; Mac Domhnaill E; Murray D; Meldrum D; Bede P; Bolger A; Hederman L; Impey S; Stephens G; O'Meara C; Wade V; Al Chalabi A; Chio A; Corcia P; van Damme P; Ingre C; McDermott C; Povedanos M; Van den Berg L; Hardiman O
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2023;24(3-4):237-245
Dying from ALS in Sweden: clinical status, setting, and symptoms
Sennfalt S; Klappe U; Thams S; Samuelsson K; Press R; Fang F; Ingre C
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2023;24(1-2):45-53
The path to diagnosis in ALS: delay, referrals, alternate diagnoses, and clinical progression
Sennfalt S; Klappe U; Thams S; Samuelsson K; Press R; Fang F; Ingre C
Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1241199
Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay
Kmezic I; Gustafsson R; Fink K; Svenningsson A; Samuelsson K; Ingre C; Olsson T; Hansson M; Kockum I; Adzemovic MZ; Press R
Article: TRIALS. 2022;23(1):978
Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial
Willemse SW; Roes KCB; Van Damme P; Hardiman O; Ingre C; Povedano M; Wray NRR; Gijzen M; de Pagter MS; Demaegd KC; Janse AFC; Vink RG; Sleutjes BTHM; Chio A; Corcia P; Reviers E; Al-Chalabi A; Kiernan MC; van den Berg LH; van Es MA; van Eijk RPA
Article: NATURE COMMUNICATIONS. 2022;13(1):6733
T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression
Yazdani S; Seitz C; Cui C; Lovik A; Pan L; Piehl F; Pawitan Y; Klappe U; Press R; Samuelsson K; Yin L; Vu TN; Joly A-L; Westerberg LS; Evertsson B; Ingre C; Andersson J; Fang F
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2022;23(7-8):481-488
Clinical trials in pediatric ALS: a TRICALS feasibility study
Kliest T; Van Eijk RPA; Al-Chalabi A; Albanese A; Andersen PM; Amador MDM; BrAthen G; Brunaud-Danel V; Brylev L; Camu W; De Carvalho M; Cereda C; Cetin H; Chaverri D; Chio A; Corcia P; Couratier P; De Marchi F; Desnuelle C; Van Es MA; Esteban J; Filosto M; Redondo AG; Grosskreutz J; Hanemann CO; Holmoy T; Hoyer H; Ingre C; Koritnik B; Kuzma-Kozakiewicz M; Lambert T; Leigh PN; Lunetta C; Mandrioli J; Mcdermott CJ; Meyer T; Mora JS; Petri S; Povedano M; Reviers E; Riva N; Roes KCB; Rubio MA; Salachas F; Sarafov S; SorarU G; Stevic Z; Svenstrup K; Moller AT; Turner MR; Van Damme P; Van Leeuwen LAG; Varona L; Costa JFV; Weber M; Hardiman O; Van den Berg LH
Article: PLOS MEDICINE. 2022;19(9):e1004092
Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden
Sun J; Ludvigsson JF; Ingre C; Piehl F; Wirdefeldt K; Zagai U; Ye W; Fang F
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2022;23(3-4):209-219
ALS patients with concurrent neuroinflammatory disorders; a nationwide clinical records study
Longinetti E; Sveinsson O; Press R; Ye W; Ingre C; Piehl F; Fang F
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2022;23(3-4):226-235
Mortality among family members of patients with amyotrophic lateral sclerosis - a Swedish register-based study
Klappe U; Longinetti E; Larsson H; Ingre C; Fang F
Article: ELIFE. 2022;11:e74065
Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis
Cui C; Ingre C; Yin L; Li X; Andersson J; Seitz C; Ruffin N; Pawitan Y; Piehl F; Fang F
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2022;23(1-2):58-65
Cardiac troponin T is elevated and increases longitudinally in ALS patients
Klappe U; Chamoun S; Shen Q; Finn A; Evertsson B; Zetterberg H; Blennow K; Press R; Samuelsson K; Manberg A; Fang F; Ingre C
Article: LANCET NEUROLOGY. 2021;20(10):821-831
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study) : a randomised, double-blind, placebo-controlled phase 3 trial
Cudkowicz M; Genge A; Maragakis N; Petri S; van den Berg L; Aho VV; Sarapohja T; Kuoppamaki M; Garratt C; Al-Chalabi A
Article: NATURE MEDICINE. 2021;27(4):640-646
Altered perivascular fibroblast activity precedes ALS disease onset
Manberg A; Skene N; Sanders F; Trusohamn M; Remnestal J; Szczepinska A; Aksoylu IS; Lonnerberg P; Ebarasi L; Wouters S; Lehmann M; Olofsson J; von Gohren Antequera I; Domaniku A; De Schaepdryver M; De Vocht J; Poesen K; Uhlen M; Anink J; Mijnsbergen C; Vergunst-Bosch H; Hubers A; Klappe U; Rodriguez-Vieitez E; Gilthorpe JD; Hedlund E; Harris RA; Aronica E; Van Damme P; Ludolph A; Veldink J; Ingre C; Nilsson P; Lewandowski SA
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2020;27(11):2125-2133
Blood biomarkers and prognosis of amyotrophic lateral sclerosis
Sun J; Carrero JJ; Zagai U; Evans M; Ingre C; Pawitan Y; Fang F
Article: MINERVA GASTROENTEROLOGICA E DIETOLOGICA. 2020;66(3):219-224
Effectiveness of percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis
Elbe P; Markus K; Valente R; Ingre C; Tsolakis AV; Vujasinovic M
Article: SCIENTIFIC REPORTS. 2020;10(1):13371
No association between proton pump inhibitor use and ALS risk: a nationwide nested case-control study
Cetin H; Sun J; Almqvist C; Reichardt B; Tomschik M; Zimprich F; Fang F; Ingre C
Article: BRAIN COMMUNICATIONS. 2020;2(2):fcaa152
Creatinine and C-reactive protein in amyotrophic lateral sclerosis, multiple sclerosis and Parkinson's disease
Cui C; Sun J; Pawitan Y; Piehl F; Chen H; Ingre C; Wirdefeldt K; Evans M; Andersson J; Carrero J-J; Fang F
Article: NEUROLOGY. 2020;94(17):E1835-E1844
Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis.
Ingre C; Chen L; Zhan Y; Termorshuizen J; Yin L; Fang F
Article: LAKARTIDNINGEN. 2020;117:FX4H
[Quality of life the goal of care for patients with ALS].
Ingre C; Nygren I; Zachau A; Staaf G
Article: ANNALS OF NEUROLOGY. 2019;86(6):913-926
Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow-up
Yazdani S; Mariosa D; Hammar N; Andersson J; Ingre C; Walldius G; Fang F
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2019;26(11):1355-1361
Antibiotics use and risk of amyotrophic lateral sclerosis in Sweden
Sun J; Zhan Y; Mariosa D; Larsson H; Almqvist C; Ingre C; Zagai U; Pawitan Y; Fang F
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2019;54(4):513-518
Complications and outcome of percutaneous endoscopic gastrostomy in a high-volume centre
Vujasinovic M; Ingre C; Silva FB; Frederiksen F; Yu J; Elbe P
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2018;19(7-8):528-537
The Swedish motor neuron disease quality registry
Longinetti E; Wallin AR; Samuelsson K; Press R; Zachau A; Ronnevi L-O; Kierkegaard M; Andersen PM; Hillert J; Fang F; Ingre C
Article: NEUROLOGY. 2017;89(6):578-585
Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis.
Longinetti E; Mariosa D; Larsson H; Ye W; Ingre C; Almqvist C; Lichtenstein P; Piehl F; Fang F
Article: ANNALS OF NEUROLOGY. 2017;81(5):718-728
Blood Biomarkers of Carbohydrate, Lipid, and Apolipoprotein Metabolisms and Risk of Amyotrophic Lateral Sclerosis: A More Than 20-Year Follow-up of the Swedish AMORIS Cohort
Mariosa D; Hammar N; Malmstrom H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2016;370:269-273
Predictors of health-related quality of life in people with amyotrophic lateral sclerosis
Sandstedt P; Johansson S; Ytterberg C; Ingre C; Holmqvist LW; Kierkegaard M
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2016;17(5-6):452-457
A 50bp deletion in the SOD1 promoter lowers enzyme expression but is not associated with ALS in Sweden
Ingre C; Wuolikainen A; Marklund SL; Birve A; Press R; Andersen PM
Article: NEUROLOGY. 2016;86(24):2271-2277
Depression in amyotrophic lateral sclerosis
Roos E; Mariosa D; Ingre C; Lundholm C; Wirdefeldt K; Roos PM; Fang F
Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2016;31(3):247-253
Amyotrophic lateral sclerosis among cross-country skiers in Sweden
Fang F; Hallmarker U; James S; Ingre C; Michaelsson K; Ahlbom A; Feychting M
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2013;14(7-8):620-627
No association between VAPB mutations and familial or sporadic ALS in Sweden, Portugal and Iceland
Ingre C; Pinto S; Birve A; Press R; Danielsson O; de Carvalho M; Gudmundsson G; Andersen PM
Article: NEUROBIOLOGY OF AGING. 2013;34(6):1708.e1-1708.e6
A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts
Ingre C; Landers JE; Rizik N; Volk AE; Akimoto C; Birve A; Huebers A; Keagle PJ; Piotrowska K; Press R; Andersen PM; Ludolph AC; Weishaupt JH
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2012;20(5):588-591
Homozygous SMN2 deletion is a protective factor in the Swedish ALS population
Corcia P; Ingre C; Blasco H; Press R; Praline J; Antar C; Veyrat-Durebex C; Guettard Y-O; Camu W; Andersen PM; Vourc'h P; Andres CR
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2011;108(52):20881-20890
A yeast functional screen predicts new candidate ALS disease genes
Couthouis J; Hart MP; Shorter J; DeJesus-Hernandez M; Erion R; Oristano R; Liu AX; Ramos D; Jethava N; Hosangadi D; Epstein J; Chiang A; Diaz Z; Nakaya T; Ibrahim F; Kim H-J; Solski JA; Williams KL; Mojsilovic-Petrovic J; Ingre C; Boylan K; Graff-Radford NR; Dickson DW; Clay-Falcone D; Elman L; McCluskey L; Greene R; Kalb RG; Lee VM-Y; Trojanowski JQ; Ludolph A; Robberecht W; Andersen PM; Nicholson GA; Blair IP; King OD; Bonini NM; Van Deerlin V; Rademakers R; Mourelatos Z; Gitler AD
Article: ANNALS OF NEUROLOGY. 2011;70(6):964-973
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis
van Es MA; Schelhaas HJ; van Vught PWJ; Ticozzi N; Andersen PM; Groen EJN; Schulte C; Blauw HM; Koppers M; Diekstra FP; Fumoto K; LeClerc AL; Keagle P; Bloem BR; Scheffer H; van Nuenen BFL; van Blitterswijk M; van Rheenen W; Wills A-M; Lowe PP; Hu G-F; Yu W; Kishikawa H; Wu D; Folkerth RD; Mariani C; Goldwurm S; Pezzoli G; Van Damme P; Lemmens R; Dahlberg C; Birve A; Fernandez-Santiago R; Waibel S; Klein C; Weber M; van der Kooi AJ; de Visser M; Verbaan D; van Hilten JJ; Heutink P; Hennekam EAM; Cuppen E; Berg D; Brown RHJ; Silani V; Gasser T; Ludolph AC; Robberecht W; Ophoff RA; Veldink JH; Pasterkamp RJ; de Bakker PIW; Landers JE; van de Warrenburg BP; van den Berg LH
Article: HUMAN MOLECULAR GENETICS. 2011;20(9):1697-1700
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients
Lee T; Li YR; Ingre C; Weber M; Grehl T; Gredal O; de Carvalho M; Meyer T; Tysnes O-B; Auburger G; Gispert S; Bonini NM; Andersen PM; Gitler AD
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2010;81(5):562-566
Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis
van Es MA; Dahlberg C; Birve A; Veldink JH; van den Berg LH; Andersen PM
Article: NATURE GENETICS. 2009;41(10):1083-1087
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis
van Es MA; Veldink JH; Saris CGJ; Blauw HM; van Vught PWJ; Birve A; Lemmens R; Schelhaas HJ; Groen EJN; Huisman MHB; van der Kooi AJ; de Visser M; Dahlberg C; Estrada K; Rivadeneira F; Hofman A; Zwarts MJ; van Doormaal PTC; Rujescu D; Strengman E; Giegling I; Muglia P; Tomik B; Slowik A; Uitterlinden AG; Hendrich C; Waibel S; Meyer T; Ludolph AC; Glass JD; Purcell S; Cichon S; Noethen MM; Wichmann H-E; Schreiber S; Vermeulen SHHM; Kiemeney LA; Wokke JHJ; Cronin S; McLaughlin RL; Hardiman O; Fumoto K; Pasterkamp RJ; Meininger V; Melki J; Leigh PN; Shaw CE; Landers JE; Al-Chalabi A; Brown RHJ; Robberecht W; Andersen PM; Ophoff RA; van den Berg LH
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2007;78(7):754-756
Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes
Schymick JC; Yang Y; Andersen PM; Vonsattel JP; Greenway M; Momeni P; Elder J; Chio A; Restagno G; Robberecht W; Dahlberg C; Mukherjee O; Goate A; Graff-Radford N; Caselli RJ; Hutton M; Gass J; Cannon A; Rademakers R; Singleton AB; Hardiman O; Rothstein J; Hardy J; Traynor BJ
Visa fler

Alla övriga publikationer

Review: REVUE NEUROLOGIQUE. 2024;:S0035-3787(24)00529-0
Could PLS represent a UMN-predominant ALS syndrome?
Corcia P; Couratier P; Ingre C
Review: SYSTEMATIC REVIEWS. 2024;13(1):111
The usage of population and disease registries as pre-screening tools for clinical trials, a systematic review
Foucher J; Azizi L; Oeijerstedt L; Klaeppe U; Ingre C
Review: NATURE REVIEWS NEUROLOGY. 2023;19(12):754-768
Biomarkers in amyotrophic lateral sclerosis: current status and future prospects
Mcmackin R; Bede P; Ingre C; Malaspina A; Hardiman O
Review: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2023;94(8):649-656
UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic target
Willemse SW; Harley P; van Eijk RPA; Demaegd KC; Zelina P; Pasterkamp RJ; van Damme P; Ingre C; van Rheenen W; Veldink JH; Kiernan MC; Al-Chalabi A; van den Berg LH; Fratta P; van Es MA
Review: BMC MEDICINE. 2022;20(1):251
Medication use and risk of amyotrophic lateral sclerosis-a systematic review
Cui C; Sun J; McKay KA; Ingre C; Fang F
Review: FRONTIERS IN NEUROLOGY. 2022;13:947347
Structural magnetic resonance imaging findings and histopathological correlations in motor neuron diseases-A systematic review and meta-analysis
Zejlon C; Nakhostin D; Winklhofer S; Pangalu A; Kulcsar Z; Lewandowski S; Finnsson J; Piehl F; Ingre C; Granberg T; Ineichen BV
Corrigendum: NATURE MEDICINE. 2021;27(7):1308
Altered perivascular fibroblast activity precedes ALS disease onset (vol 27, pg 640, 2021)
Manberg A; Skene N; Sanders F; Trusohamn M; Remnestal J; Szczepinska A; Aksoylu IS; Lonnerberg P; Ebarasi L; Wouters S; Lehmann M; Olofsson J; von Gohren Antequera I; Domaniku A; De Schaepdryver M; De Vocht J; Poesen K; Uhlen M; Anink J; Mijnsbergen C; Vergunst-Bosch H; Hubers A; Klappe U; Rodriguez-Vieitez E; Gilthorpe JD; Hedlund E; Harris RA; Aronica E; Van Damme P; Ludolph A; Veldink J; Ingre C; Nilsson P; Lewandowski SA
Review: ACTA NEUROLOGICA SCANDINAVICA. 2021;143(1):39-50
Military service and related risk factors for amyotrophic lateral sclerosis
McKay KA; Smith KA; Smertinaite L; Fang F; Ingre C; Taube F
Review: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2020;21(7-8):496-501
TRICALS: creating a highway toward a cure
van Eijk RPA; Kliest T; McDermott CJ; Roes KCB; Van Damme P; Chio A; Weber M; Ingre C; Corcia P; Povedano M; Reviers E; van Es MA; Al-Chalabi A; Hardiman O; van den Berg LH
Editorial comment: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2017;18(7-8):471-474
July 2017 ENCALS statement on edaravone
Al-Chalabi A; Andersen PM; Chandran S; Chio A; Corcia P; Couratier P; Danielsson O; de Carvalho M; Desnuelle C; Grehl T; Grosskreutz J; Holmoy T; Ingre C; Karlsborg M; Kleveland G; Christoph Koch J; Koritnik B; KuzmaKozakiewicz M; Laaksovirta H; Ludolph A; McDermott C; Meyer T; Ropero BM; Pardina JM; Nygren I; Petri S; Povedano Panades M; Salachas F; Shaw P; Silani V; Staaf G; Svenstrup K; Talbot K; Tysnes O-B; Van Damme P; van der Kooi A; Weber M; Weydt P; Wolf J; Hardiman O; van den Berg LH
Review: CLINICAL EPIDEMIOLOGY. 2015;7:181-193
Risk factors for amyotrophic lateral sclerosis
Ingre C; Roos PM; Piehl F; Kamel F; Fang F

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI